High Potency Active Pharmaceutical Ingredients (APIs) Market Expected To Encourage Expansion At USD 34.8 Billion By 2025 : Grand View Research Inc.
San Francisco, 24 May 2019: The Report High Potency Active Pharmaceutical Ingredients (APIs) Market Analysis By Product (Synthetic, Biotech), Manufacturer (In-house, Outsourced), Drug Type, Therapeutic Application (Oncology, Hormonal, Glaucoma, Others), And Segment Forecasts, 2018 – 2025
The global High Potency Active Pharmaceutical Ingredients (APIs) Market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.
In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.
Access Research Report of High Potency Active Pharmaceutical Ingredients (APIs) Market @ www.grandviewresearch.com/industry-analysis/high-potency-active-pharmaceutical-ingredients-hpapi-market
Further Key Findings From the Study Suggest:
Grand View Research has segmented the High PotencyAPIsmarket on the basis of the product, manufactures, drug types, application, and region:
HPAPIs Product Outlook (Revenue, USD Million, 2014 - 2025)
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
The global High Potency Active Pharmaceutical Ingredients (APIs) Market is expected to reach USD 34.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.
In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.
Access Research Report of High Potency Active Pharmaceutical Ingredients (APIs) Market @ www.grandviewresearch.com/industry-analysis/high-potency-active-pharmaceutical-ingredients-hpapi-market
Further Key Findings From the Study Suggest:
- Synthetic route of High PotencyAPIs dominated the overall market in terms of revenue share as of 2016 owing to presence of large manufacturers producing these type of molecules
- Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it
- Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment
- Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development
- Oncology segment heldlargest revenue share as of 2016, due to increasing demand for anti-cancerous drugs
- North America HPAPIs market held the largest market share as of 2016. Growing prevalence of chronic disease patients, and established research and development infrastructure for novel drug development are factors supporting to major share of this market
- Patent expiration of major drugs in North American and European countries is anticipated to fuel market growth
- Asia Pacific regional market is expected to register significant growth owing to growing investments in biotechnology sector and rapidly growing oncology market
- The key players in the HPAPI market includeBristol-Myers Squibb, Sigma-Aldrich Corporation, Pfizer Incand Lonza among others
- Extensive research and development activities carried out by market participants is also expected to augment the market growth
Grand View Research has segmented the High PotencyAPIsmarket on the basis of the product, manufactures, drug types, application, and region:
HPAPIs Product Outlook (Revenue, USD Million, 2014 - 2025)
- Synthetic
- Biotech
- In-house
- Outsourced
- Innovative
- Generic
- Oncology
- Hormonal
- Glaucoma
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Comments
Post a Comment